Clinical Trial Update: First in Human Study of SIM0610 in Solid Tumors [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of SIM0610 in solid tumors is underway, evaluating safety and dosing across multiple indications including Non-Small Cell Lung Ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Head and Neck Squamous Cell Carcinoma
• Hepatocellular Carcinoma
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• SIM0610

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumours, Non-Small Cell Lung Cancer | Phase 1 | Status: RECRUITING